Popular Content
Surrogacy in Singapore - Should the Current Ban be Lifted?
As Singapore confronts falling birth rates and an ageing population, its surrogacy ban faces new scrutiny. A very narrow, altruistic framework for legally-married heterosexual couples with genuine medical need is proposed, backed by independent oversight, clear legal rules, and relevant safeguards.
PGT-A in Singapore: Should it be routinely used for older women (Advanced Maternal Age)?
PGT-A is often sold as a high-tech shield against miscarriage and Down syndrome for women having children later in life. But the best evidence does not show that age alone makes the test worth doing routinely. It may help some patients—yet it can potentially damage embryos and lead to misdiagnosis.
ETHICAL, LEGAL AND SOCIAL ISSUES IN HUMAN BRAIN ORGANOID RESEARCH - a hypothetical public consultation paper in anticipation of future actions by the Bioethics Advisory Committee (BAC) of Singapore
This is an independent, hypothetical public consultation paper on human brain organoids for discussion and educational purposes only. It has not been issued, approved, or endorsed by the Bioethics Advisory Committee of Singapore, the Ministry of Health, or any other Singapore Government agency.
ETHICAL, LEGAL, AND SOCIAL ISSUES ARISING FROM RESEARCH ON HUMAN STEM CELL-BASED EMBRYO MODELS - a legal grey area requiring future public consultation by the Bioethics Advisory Committee (BAC) of Singapore
Existing laws like Singapore's Human Biomedical Research Act and the Human Cloning Act define embryos based on fertilization. Because SCBEMs do not involve fertilization, they currently sit in a regulatory gap, necessitating a public consultation by Singapore's Bioethics Advisory Committee (BAC).
Singapore’s Fertility Health Support and Increased Financial Assistance for IVF and other Assisted Conception Procedures must Safeguard against Wasteful Medical Spending
Increased public funding of fertility treatments risks freeing spare cash for doubtful medical extras. Singapore must fund evidence-based treatment, not clinic upselling. The Ministry of Health (MOH) should adopt a traffic-light rating for IVF add-ons similar to that developed by HFEA in the UK.